Cargando…
A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection
Chagas disease, caused by the parasite Trypanosoma cruzi, develops into chronic Chagas’ cardiomyopathy in ~30% of infected individuals, characterized by conduction disorders, arrhythmias, heart failure, and even sudden cardiac death. Current anti-parasitic treatments are plagued by significant side...
Autores principales: | Barry, Meagan A., Versteeg, Leroy, Wang, Qian, Pollet, Jeroen, Zhan, Bin, Gusovsky, Fabian, Bottazzi, Maria Elena, Hotez, Peter J., Jones, Kathryn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542517/ https://www.ncbi.nlm.nih.gov/pubmed/31145733 http://dx.doi.org/10.1371/journal.pntd.0007413 |
Ejemplares similares
-
The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection
por: Nguyen, Duc Minh, et al.
Publicado: (2023) -
The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection
por: Nguyen, Duc Minh, et al.
Publicado: (2023) -
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
por: Cruz-Chan, Julio V., et al.
Publicado: (2021) -
Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi
por: Versteeg, Leroy, et al.
Publicado: (2021) -
Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)